Stocktoria
Forte Biosciences, Inc. FBRX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-04-13
Forte Biosciences, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | — | -11288.9% | -254.2% | -91775.6% | -64673.5% |
| Net margin | — | — | — | — | — | — | -11302.8% | -271.4% | -94948.8% | -68322.4% |
| FCF margin | — | — | — | — | — | — | -8147.2% | -202.0% | -77531.7% | -61355.1% |
| Return on assets | -83.8% | -57.6% | -80.7% | -33.0% | -50.1% | -75.9% | -53.1% | -47.5% | -42.3% | -94.7% |
| Return on equity | -113.7% | -67.6% | -89.1% | -35.8% | -52.2% | -78.8% | 85.3% | 6651.5% | -54.8% | 26.9% |
| Debt / equity | — | — | — | — | — | — | — | -35.60× | 0.05× | -0.08× |
| Current ratio | 3.88 | 6.76 | 10.45 | 13.06 | 24.19 | 26.52 | 3.93 | 5.91 | 5.23 | 2.26 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.